Ticker Shock: Bad News For Coke, Good News for eBay
Monday's top stories and stocks with potential to move.
Let the pummeling begin: European markets saw mid-single-digit percentage losses, with big banks taking a hit. Major Asian markets are off in the 4% to 5% range. The Dow is off triple digits; the NASDAQ and S&P are lower as well.
The only positive is that oil is down around $90 a barrel - a level it certainly hasn't seen in a while.
There's talk of splitting Wachovia in two, with some to go to Citi (C), some to Wells Fargo (WFC). The Federal Reserve is reportedly pushing that arrangement. Wells Fargo may be winning the battle in the courts, however, at least for now: Citigroup's request for an extension of time in which to complete the deal was thrown out by the judge presiding over the case.
I wouldn't wait for this tug of war to play out. If I were long Wachovia -- especially when it was trading in the $1 range -- I'd bail. I simply don't think that the potential reward is worth the risk at this point.
Well, it's official: Eli Lilly (LLY) is set to acquire biotech ImClone for $70 a share in cold hard cash. The big question now is whether Bristol-Myers (BMY) will man up and raise its $62 per share bid to get back in the game - and I think there's a good chance that could happen. However, it'd have to come in at least a buck or 2 north of the Lilly offer in order for Icahn and crew to go along with it at this point.
ImClone has opened higher. If it trades above $68, I'd probably bail rather than wait for Bristol-Myers to possibly step up, or for the Lilly deal to close. Late in the fourth quarter or early in the first quarter is the expected close date.
Minyanville's Buzz & Banter - 14 day FREE trial
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter